Cytotoxicity mechanisms of passive anti-GD2 immunotherapy in pediatric tumors
Cells of neuroblastoma, soft tissue sarcomas, osteosarcoma, Ewing’s sarcoma and some other tumors in children and adults are able to express disialogangliside GD2. The introduction of anti-GD2 monoclonal antibodies into neuroblastoma treatment protocols has improved outcomes. Studies of the effectiv...
Saved in:
| Main Authors: | M. E. Melnikov, S. A. Kulyova, G. V. Kondratiev, M. M. Vasilyeva, O. E. Savelieva |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2025-06-01
|
| Series: | Успехи молекулярной онкологии |
| Subjects: | |
| Online Access: | https://umo.abvpress.ru/jour/article/view/784 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunology and prospects of immunotherapy against malignant gliomas: humoral immunity
by: S. A. Kulyova, et al.
Published: (2021-12-01) -
Dual-labeled anti-GD2 targeted probe for intraoperative molecular imaging of neuroblastoma
by: Lauren Taylor Rosenblum, et al.
Published: (2024-10-01) -
Novel drug - dinutuximab for high-risk neuroblastoma
by: Supriya Kushwah, et al.
Published: (2018-01-01) -
FUNCTIONAL ACTIVITY OF ANTI-GD2 CAR-T CELLS WITH DIFFERENT ANTIGEN-RECOGNITION MODULE
by: Dzmitry Lutskovich, et al.
Published: (2019-08-01) -
Preparation of Monoclonal Antibodies Against the gD Protein of Feline Herpesvirus Type-1 by mRNA Immunization
by: Chengqi Zhang, et al.
Published: (2025-06-01)